Brausi M - Search Results

1

High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group.

Brausi M, Jones WG, Fosså SD, de Mulder PH, Droz JP, Lentz MA, van Glabbeke M, Pawinski A. Brausi M, et al. Eur J Cancer. 1995 Sep;31A(10):1622-6. doi: 10.1016/0959-8049(95)00193-m. Eur J Cancer. 1995. PMID: 7488412 Clinical Trial.

2

Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.

MacLennan S, Azevedo N, Duncan E, Dunsmore J, Fullwood L, Lumen N, Plass K, Ribal MJ, Roobol MJ, Nieboer D, Schouten N, Skolarus TA, Smith EJ, N'Dow J, Mottet N, Briganti A; Pan-European National Urological Society IMAGINE Collaborative (see Supplemental material for group members affiliations):. MacLennan S, et al. Eur Urol. 2023 May;83(5):393-401. doi: 10.1016/j.eururo.2022.12.031. Epub 2023 Jan 11. Eur Urol. 2023. PMID: 36639296 Free article.

3

Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.

Fosså SD, Slee PH, Brausi M, Horenblas S, Hall RR, Hetherington JW, Aaronson N, de Prijck L, Collette L. Fosså SD, et al. Among authors: brausi m. J Clin Oncol. 2001 Jan 1;19(1):62-71. doi: 10.1200/JCO.2001.19.1.62. J Clin Oncol. 2001. PMID: 11134196 Clinical Trial.

4

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).

Studer UE, Collette L, Whelan P, Albrecht W, Casselman J, de Reijke T, Knönagel H, Loidl W, Isorna S, Sundaram SK, Debois M; EORTC Genitourinary Group. Studer UE, et al. Eur Urol. 2008 May;53(5):941-9. doi: 10.1016/j.eururo.2007.12.032. Epub 2007 Dec 27. Eur Urol. 2008. PMID: 18191322 Clinical Trial.

5

Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.

Frassoldati A, Federico M, Barbieri F, Brausi M, Pollastri C, Berri G, Castagnetti G, Palladini PP, Silingardi V. Frassoldati A, et al. Among authors: brausi m. Med Oncol Tumor Pharmacother. 1991;8(2):99-103. doi: 10.1007/BF02988861. Med Oncol Tumor Pharmacother. 1991. PMID: 1749307

6

Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: a comparative Phase II study.

Brausi M, Campo B, Pizzocaro G, Rigatti P, Parma A, Mazza G, Vicini A, Stephen RL. Brausi M, et al. Urology. 1998 Mar;51(3):506-9. doi: 10.1016/s0090-4295(97)00625-0. Urology. 1998. PMID: 9510365 Clinical Trial.

7

Quality control of radical prostatectomy: a feasibility study.

Van Poppel H, Collette L, Kirkali Z, Brausi M, Hoekstra W, Newling DW, Decoster M; EORTC GU Group. Van Poppel H, et al. Among authors: brausi m. Eur J Cancer. 2001 May;37(7):884-91. doi: 10.1016/s0959-8049(01)00056-9. Eur J Cancer. 2001. PMID: 11313177 Clinical Trial.

8

Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.

Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S. Scaltriti M, et al. Among authors: brausi m. Int J Cancer. 2004 Jan 1;108(1):23-30. doi: 10.1002/ijc.11496. Int J Cancer. 2004. PMID: 14618611

9

Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?

Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM. Brausi M, et al. J Urol. 2004 Sep;172(3):906-8; discussion 908-9. doi: 10.1097/01.ju.0000134622.54235.93. J Urol. 2004. PMID: 15310995

10

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Bettuzzi S, et al. Among authors: brausi m. Cancer Res. 2006 Jan 15;66(2):1234-40. doi: 10.1158/0008-5472.CAN-05-1145. Cancer Res. 2006. PMID: 16424063 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page